Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
A real-world study evaluating IL-23 inhibitors in patients with active Crohn's disease is currently recruiting at the Sixth Affiliated Hospi…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Efficacy and Safety of CDED With Anti-TNF-α Biologics in Crohn's Disease [NA]
The document reports a clinical trial evaluating the combination of the Crohn's Disease Exclusion Diet (CDED) with anti-TNF-α biologics for …
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease. [Phase 2]
A Phase 2 clinical trial evaluating whether fluconazole affects ASCA antibody levels after Crohn's disease surgical resection has completed.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO [Phase 1]
Phase 1 trial evaluating nivolumab in patients with autoimmune disorders and advanced cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease [Phase 3]
Phase 3 clinical trial update for guselkumab in fistulizing, perianal Crohn's disease; the study is active but not currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease [Phase 2]
A Phase 2 clinical trial update evaluating the combination of LY4395089 and mirikizumab, and mirikizumab alone, in adults with Crohn's disea…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis
This completed clinical trial evaluated physical fitness levels in children and adolescents with chronic inflammatory bowel disease, includi…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
This is a real-world clinical trial in Saudi Arabia evaluating guselkumab for ulcerative colitis and Crohn's disease, with status not yet re…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. [Phase 2]
Sanofi is conducting a Phase 2 trial to evaluate the efficacy and safety of SAR441566 in Crohn's disease. Recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe [NA]
Massachusetts General Hospital reports an ongoing clinical trial using a colonoscope-compatible thermal probe to measure gut temperature in …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study
This multicenter prospective observational trial investigates whether intestinal ultrasound can predict clinical relapse in Crohn's disease …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease [Phase 3]
A Phase 3 clinical trial update evaluating pharmacokinetics, effectiveness, and safety of Afimkibart for induction and maintenance therapy i…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight [Phase 3]
A Phase 3 trial assessing Mirikizumab and Tirzepatide in adults with moderately to severely active Crohn's disease and obesity or overweight…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
The COMPARE trial for pediatric inflammatory bowel disease is currently recruiting, evaluating treatments for pediatric ulcerative colitis a…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Oral N-acetylglucosamine in Crohn's Disease [Phase 2]
A Phase 2 clinical trial evaluating oral N-acetylglucosamine for Crohn's disease is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Culturally Tailored Dietary Intervention to Treat Crohn's Disease [NA]
A clinical trial update describes a culturally tailored dietary intervention aimed at treating Crohn's disease; the study is listed as activ…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) [Phase 3]
This is a Phase 3 master protocol study (SHINE-ON) evaluating Mirikizumab (LY3074828) in pediatric participants with Ulcerative colitis or C…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease [Phase 2]
A Phase 2 clinical trial evaluating MORF-057 in adults with moderately to severely active Crohn's disease is currently recruiting, sponsored…
-
EMA approval · 2026-04-16EMA Authorised: Steqeyma (ustekinumab) — Celltrion Healthcare Hungary Kft.
The EMA authorised Steqeyma (ustekinumab) by Celltrion Healthcare Hungary Kft for psoriasis, psoriatic arthritis, and Crohn's disease.
-
EMA approval · 2026-04-16EMA Authorised: Qoyvolma (ustekinumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Qoyvolma (ustekinumab) by Celltrion Healthcare Hungary Kft. for psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating mesenchymal stem cell therapy for ileal pouch fistulas in Crohn's disease participants has been termin…
-
CLINICAL_TRIALS withdrawal · 2026-04-16Clinical Trial Update: Stem Cells for the Treatment of Pouchitis [Phase 1]
The Cleveland Clinic's Phase 1 stem cell trial for pouchitis has been withdrawn.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 3]
This is a Phase 3 clinical trial evaluating vedolizumab in children with ulcerative colitis or Crohn's disease; recruitment is currently ong…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease [Phase 1]
Phase 1 pediatric trial using mesenchymal stem cells to treat perianal fistulas in Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis [Phase 1, Phase 2]
Phase 1/2 trial evaluating mesenchymal stem cell therapy for medically refractory Crohn's colitis was terminated.